Moolec Science S.A. operates as a science-driven ingredient company focused on generating animal proteins inside plants through a groundbreaking method called Molecular Farming. This innovative approach is considered a disruptive force in the alternative protein sector. The firm's existing and future products strategically utilize the strong agricultural performance of key crops, such as soybeans and peas. Established in 2008, Moolec Science S.A. is headquartered in Luxembourg and conducts business across the United States, Europe, and South America.
Previous close
$0.007
+$0.00 · +0.01%
Regular session · ET · Market data may be delayed.
Moolec Science S.A. operates as a science-driven ingredient company focused on generating animal proteins inside plants through a groundbreaking method called Molecular Farming. This innovative approach is considered a disruptive force in the alternative protein sector. The firm's existing and future products strategically utilize the strong agricultural performance of key crops, such as soybeans and peas. Established in 2008, Moolec Science S.A. is headquartered in Luxembourg and conducts business across the United States, Europe, and South America.
Day range
Current $0.007
52-week range
Current $0.007
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
79
Undervalued
Sentiment
48
Mixed
Risk
44
Elevated Risk
Momentum
42
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Moolec Science S.A. operates as a science-driven ingredient company focused on generating animal proteins inside plants through a groundbreaking method called Molecular Farming. This innovative approach is considered a disruptive force in the alternative protein sector. The firm's existing and future products strategically utilize the strong agricultural performance of key crops, such as soybeans and peas. Established in 2008, Moolec Science S.A. is headquartered in Luxembourg and conducts business across the United States, Europe, and South America.
Day range
Current $0.007
52-week range
Current $0.007
Recent quarterly results
Recent quarterly results
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.